Key result
Central obesity is associated with pathological changes in blood lipid profiles and glycaemic control that contribute to cardiovascular damage.
The current obesity pandemic is recognised as a major factor contributing to the global burden of disease. Indeed, the rising tide of obesity in the USA and Europe has been shown to contribute directly to high levels of type 2 diabetes, cardiovascular disease and certain cancers. Increases in body weight leading to central obesity are associated with pathological changes in blood lipid profiles, predisposing subjects to atherosclerosis, and with metabolic changes in glycaemic control that contribute to cardiovascular damage.
No takes yet. Share an insight, caveat, or question.
Anthony Barnett (2006) conducted a review in Obesity and cardiovascular risk. Rimonabant was evaluated. Central obesity is associated with pathological changes in blood lipid profiles and glycaemic control that contribute to cardiovascular damage.
Synapse has enriched 5 related papers. Consider them for comparative context: